Taken above, demonstrating whether CDK5 is involved in blocking BIN1/c-MYC interaction is beneficial for comprehending the biological function of CDK5 to establish novel therapeutic strategies in treating NSCLC. This evidence concerns the gene CDK5 and non-small cell lung carcinoma.